In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Meridian Diagnostics

This article was originally published in The Gray Sheet

Executive Summary

Expands line of enzyme immunoassay and fluorescent antibody offerings with purchase of Johnson & Johnson infectious disease products. In exchange for $3.3 mil. cash "plus inventory and additional future royalty payments," Meridian is gaining products to aid in the diagnosis of "certain viral diseases such as herpes, respiratory syncytial virus, chicken pox and certain serious bacterial infections such as chlamydia," a Jan. 26 release states. Annual sales from the line amount to about $5 mil. Under the terms of the deal, Meridian also "will manufacture certain products" for J&J's Ortho Diagnostic Systems



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts